Cyclic sulfone containing retroviral protease inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7112683
APP PUB NO 20050119257A1
SERIAL NO

10932331

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
G. D. Searle & Co.CHICAGO, IL176
MONSANTO COMPANYST LOUIS, MO294

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bertenshaw, Deborah E Brentwood, MO 33 364
Chrusciel, Robert A Portage, MI 12 46
Clare, Michael Skokie, IL 80 691
Getman, Daniel P Chesterfield, MO 158 998
Heintz, Robert M Ballwin, MO 63 489
Reed, Kathryn L Raleigh, NC 26 167
Talley, John J St. Louis, MO 230 2235

Cited Art Landscape

Patent Info (Count) # Cites Year
 
Other [Check patent profile for assignment information] (1)
H725 Ureido amino and imino acids, compositions and methods for use 133 1987
 
OSRAM OLED GMBH (1)
7982387 Optoelectronic component 36 2008
 
ABBOTT LABORATORIES (2)
4857507 Angiotensinogen analogs 18 1987
4977277 Functionalized peptidyl aminodiols and -triols 4-amino-5-cyclohexyl-3-hydroxy-1,2-oxopentane and derivatives thereof 135 1989
 
SCHERING CORPORATION (1)
4450164 Imidazo[1,2-A]pyridines and use 142 1982
 
PFIZER INC. (2)
4668769 Oxa- and azahomocyclostatine polypeptides 143 1985
4599198 Intermediates in polypeptide synthesis 158 1985
 
FUJISAWA PHARMACEUTICAL CO., LTD. (1)
4963530 Renin inhibitor peptide compounds, a process for the preparation thereof and pharmaceutical composition comprising the same 139 1988
 
Agouron Pharmaceuticals, Inc. (5)
5484926 HIV protease inhibitors 80 1994
5824688 HIV protease inhibitors 11 1995
5827858 HIV protease inhibitors 7 1995
5827859 HIV protease inhibitors 9 1995
5827891 HIV protease inhibtors 19 1995
 
MERCK & CO., INC. (2)
4668770 Renin inhibitory tripeptides 155 1984
4880938 Amino acid analogs 113 1986
 
SANKYO COMPANY, LIMITED (1)
4548926 Hypotensive peptides and their use 162 1984
 
MONSANTO COMPANY (5)
* 5514801 Cyclic sulfone containing retroviral protease inhibitors 10 1992
* 5849784 Cyclic sulfone containing retroviral protease inhibitors 9 1995
* 6265583 Cyclic sulfone containing retroviral protease inhibitors 3 1998
6329524 Cyclic sulfone containing retroviral protease inhibitors 1 2001
* 6552203 Cyclic sulfone containing retroviral protease inhibitors 7 2001
 
Merck & Co., Ltd. (1)
4477441 Renin inhibitors containing a C-terminal disulfide cycle 148 1983
 
E. R. Squibb & Sons, Inc. (3)
4514391 Hydroxy substituted peptide compounds 143 1983
4616088 Amino acid ester and amide renin inhibitor 153 1984
4757050 Ureido renin inhibitors 136 1987
 
PHARMACIA CORPORATION (1)
* 6875790 Cyclic sulfone containing retroviral protease inhibitors 5 2003
* Cited By Examiner

Patent Citation Ranking

Forward Cite Landscape

Patent Info (Count) # Cites Year
 
G.D. SEARLE LLC (3)
RE43596 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors 0 2007
* RE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors 1 2007
RE43802 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors 0 2011
 
G.D. Searle & Co. (now G.D. Searle, LLC) (1)
* 2007/0015,818 Cyclic sulfone containing retroviral protease inhibitors 0 2006
* Cited By Examiner

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 26, 2018
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00